Please try another search
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, postpartum and rehabilitation care, property investment, and real estate development and operation activities. Additionally, the company is involved in the sale of medicines, consumables, and equipment; and research and development of IVF related projects, including scientific research and related commercialization. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.
Name | Age | Since | Title |
---|---|---|---|
Haw Kuang Lim | 66 | 2019 | Independent Non Executive Director |
Yat Keung Chong | 58 | 2019 | Independent Non-Executive Director |
Min Fang | 42 | 2018 | Non-Executive Director |
Zhe Hu | 48 | 2018 | Non-Executive Director |
Xiaoqing Yan | 52 | 2018 | Non-Executive Director |
Xiaobo Wang | 46 | 2019 | Independent Non-Executive Director |
Jianwei Li | 49 | 2021 | Independent Non-Executive Director |
Changqing Ye | 52 | 2019 | Independent Non-Executive Director |
Rong Lyu | 42 | 2021 | CO-CEO & Executive Director |
Yong Zhong | 51 | 2018 | Executive Chairman of the Board |
Yang Dong | 37 | 2018 | Co-CEO & Executive Director |
John G. Wilcox | 59 | 2018 | Executive Director |
Lihong Geng | 54 | 2020 | Chief Medical Quality Control Officer & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review